Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma

HFCAS OpenIR

	Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
	He, Q.; Yu, X.
	2021-03-01
发表期刊	JOURNAL OF THORACIC ONCOLOGY
ISSN	1556-0864
关键词	Immunotherapy Tislelizumab Esophageal Squamous Cell Carcinoma
收录类别	SCI
语种	英语
WOS研究方向	Oncology ; Respiratory System
WOS类目	Oncology ; Respiratory System
WOS记录号	WOS:000631349600502
出版者	ELSEVIER SCIENCE INC
引用统计
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/121736
专题	中国科学院合肥物质科学研究院
作者单位	1.Chinese Acad Sci, Inst Canc & Basic Med Icbm, Hangzhou, Zhejiang, Peoples R China 2.Univ Chinese Acad Sci, Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China 3.Dept Med Oncol, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	He, Q.,Yu, X.. Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma[J]. JOURNAL OF THORACIC ONCOLOGY,2021,16.
APA	He, Q.,&Yu, X..(2021).Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma.JOURNAL OF THORACIC ONCOLOGY,16.
MLA	He, Q.,et al."Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma".JOURNAL OF THORACIC ONCOLOGY 16(2021).